Inclusion Criteria:~* Diagnosis of probable Alzheimer's disease using NINCDS-ADRDA criteria~ * Mild to moderate
degree of severity of dementia as assessed by the Mini-Mental Status Examination score of 16 to 26 (inclusive)~
* Potential participant may be treated with conventional Alzheimer's disease therapy and must be on a stable
dose for at least 6 months prior to the randomization and during the entire study period~ * Potential
participant must have a reliable caregiver and must be living in a community or in an assisted living facility~
* Mother tongue is English, Spanish or French (oral and written fluency)~ * Signed informed consent from
potential participant or legal representative and identified caregiver~
